11th Jun 2015 09:49
LONDON (Alliance News) - LiDCO Group PLC Thursday said it has got approval for reimbursement in Japan of its single patient disposable kit with effect from the beginning of June 2015.
The cardiovascular monitoring company said the kit will be reimbursed at the same rate as the existing disposable product for arterial line minimally invasive hemodynamic monitoring in the Japanese market, while offering Japanese customers the option of the additional parameter of continuous non-invasive blood pressure.
This reimbursement follows Japanese product approval for the LiDCOrapidv2 product with Unity software and continuous non-invasive blood pressure module in March 2015.
"Japan is a key territory for LiDCO as it is the second largest market in the world for our products, with approximately 680,000 high-risk surgical patients per annum. The availability of our multiparameter LiDCOrapidv2 with Unity software and continuous non-invasive blood pressure monitoring will help differentiate our product offering and build our market share in Japan," Chief Executive Terry O'Brien said.
LiDCO shares were down 3.4% at 10.75 pence Thursday morning.
By Steve McGrath; [email protected]; @stevemcgrath1
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
LID.L